Sbir phase I

Ended Purchase Order Awarded Last action

Contract number
75D30118P02041
Awardee
Awarding agency
Obligated
$149,999

Award facts

Contract value 100% obligated
$149,999.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30329, USA
Legislative mandates
  • Other statutory authority

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $149,999

About this award

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $149,999 firm-fixed-price purchase order contract to Cyanvac LLC, a minority-owned small business, for SBIR Phase I work. Cyanvac is developing viral vector vaccines, including intranasal vaccine candidates against respiratory viruses such as SARS-CoV-2, respiratory syncytial virus (RSV), and human metapneumovirus (HMPV). The company has previously received over $700,000 in prime federal grants from the National Institute of Allergy and Infectious Diseases to support the development of these viral vector vaccines. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75D30118P02041?

75D30118P02041 was awarded to Cyanvac LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 1, 2018.

How much is contract 75D30118P02041 worth?

The government has obligated $149,999 on 75D30118P02041.

Was contract 75D30118P02041 competed?

The extent of competition for 75D30118P02041 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award